Ferrlecit Injection
NDC Package 0024-2792-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Ferrlecit (sodium ferric gluconate complex) injection is ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy. This formulation utilizes a injection delivery system. Marketed by Sanofi-aventis U.s. Llc, this product is identified by NDC 0024-2792 and is authorized under FDA application NDA020955.

Identification & Billing

NDC Package Code
0024-2792-10
Package Description
10 VIAL, SINGLE-USE in 1 CARTON / 5 mL in 1 VIAL, SINGLE-USE (0024-2792-01)
Product Code
0024-2792
11-Digit Billing Format
00024279210
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 242761 - sodium ferric gluconate complex (as iron) 62.5 MG in 5 mL Injection
  • RxCUI: 242761 - 5 ML sodium ferric gluconate complex 12.5 MG/ML Injection
  • RxCUI: 242761 - sodium ferric gluconate complex (as elemental iron) 62.5 MG per 5 ML Injection
  • RxCUI: 261123 - Ferrlecit (iron) 62.5 MG in 5 mL Injection
  • RxCUI: 261123 - 5 ML sodium ferric gluconate complex 12.5 MG/ML Injection [Ferrlecit]

Clinical Specifications

Proprietary Name
Ferrlecit
Non-Proprietary Name
Sodium Ferric Gluconate Complex
Substance Name
Sodium Ferric Gluconate Complex
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
Intravenous - Administration within or into a vein or veins.
Active Ingredient(s)
SODIUM FERRIC GLUCONATE COMPLEX 12.5 mg/mL
Pharmacologic Class
Usage Information
Ferrlecit is indicated for the treatment of iron deficiency anemia in adult patients and in pediatric patients age 6 years and older with chronic kidney disease receiving hemodialysis who are receiving supplemental epoetin therapy.

Regulatory & Marketing

Labeler Name
Sanofi-aventis U.s. Llc
Product Type
Human Prescription Drug
FDA Application #
NDA020955
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-01-2011
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0024-2792-10 identifies a specific commercial package of 10 vial, single-use in 1 carton / 5 ml in 1 vial, single-use (0024-2792-01) of Ferrlecit, a human prescription drug labeled by Sanofi-aventis U.s. Llc. This injection is formulated for intravenous use and contains sodium ferric gluconate complex as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Sanofi-aventis U.s. Llc on March 01, 2011. The current certification is valid through December 31, 2026.

How is this Sanofi-aventis U.s. Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00024279210. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0024-2792-10
11-Digit CMS (5-4-2)
00024-2792-10

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.